Belinostat (PXD101)


  • Specification
  • Related Products
Cat.No.:  BSM-0198
Product Name:  Belinostat (PXD101)
CAS No.:  414864-00-9
Figure: 
Synonyms:  (E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide; Belinostat
Description:  Belinostat is a novel and potent hydroxamate-type HDAC inhibitor. It inhibits HDAC activity in HeLa cell extracts with an IC50 of 27 nM. Belinostat significantly increases acetylation of histones H3 and H4 and potently inhibits the growth of prostate cancer cell lines (IC50 range from 0.5 to 2.5 µM) with cytotoxic activity preferentially against tumor cells.
Appearance:  White solid
Molecular Weight:  318.35
Purity:  ≥98% by HPLC
Storage:  -20°C
Targets:  Histone deacetylase (HDAC) activity
Molecular Formula:  C15H14N2O4S
MDL Number:  MFCD18086851
Solubility:  DMSO (>50 mg/ml)
Shipping Conditions:  Gel Pack
Warning:  For Research Use Only! Not For Use in Humans.

Online Inquiry

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

USA

Enter your email here to subscribe.

Follow us on

Easy access to products and services you need from our library via powerful searching tools

Copyright © Creative BioMart. All Rights Reserved.